INCYTE CORP Insider Trading Activity
Every SEC Form 4 insider transaction reported for INCYTE CORP (INCY), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are INCY insiders buying or selling?
In the last 12 months, INCYTE CORP insiders reported 0 open-market purchases ($0) and 28 sales ($58.0M) — net selling of $58.0M. Since January 2018, Trabud has recorded 189 Form 4 filings for INCY: 8 buys ($288.3M) and 181 sells ($186.6M).
Source: SEC EDGAR Form 4
What stands out
- No INCYTE CORP insider made an open-market purchase in the last 12 months; the 28 reported open-market sales totaled $58.0M.
Key Statistics (January 2018 – Sep 17, 2026)
Total Form 4 filings
189
SEC EDGAR
Insider filers
24
Insider buys (8)
$288.3M
Insider sells (181)
$186.6M
Insider sentiment
Net buyingNet insider flow of $101.7M in net buying since January 2018, and $58.0M in net selling over the last 12 months.
Recent INCY insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 23.2K | $120.49 | $2.8M | SEC ↗ |
| Aug 20, 2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 10.8K | $125.56 | $1.4M | SEC ↗ |
| Aug 14, 2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 10.8K | $120.04 | $1.3M | SEC ↗ |
| Aug 7, 2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 10.6K | $122.69 | $1.3M | SEC ↗ |
| Aug 7, 2026 | Patrick A Mayes | EVP & Chief Scientific Officer | Sale | 2.2K | $123.99 | $273.6K | SEC ↗ |
| Aug 4, 2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 15.9K | $119.70 | $1.9M | SEC ↗ |
| Aug 4, 2026 | Patrick A Mayes | EVP & Chief Scientific Officer | Sale | 48.0K | $119.58 | $5.7M | SEC ↗ |
| Jul 20, 2026 | Steven H Stein | CMO & Head of Late-Stage Dev. | Sale | 1.9K | $114.73 | $215.3K | SEC ↗ |
| Jul 20, 2026 | Mohamed Khairie Issa | EVP, Head of U.S. Commercial | Sale | 1.1K | $115.01 | $125.7K | SEC ↗ |
| Jul 16, 2026 | Steven H Stein | CMO & Head of Late-Stage Dev. | Sale | 28.2K | $113.05 | $3.2M | SEC ↗ |
| Jun 8, 2026 | Thomas Tray | Principal Accounting Officer | Sale | 2.6K | $100.00 | $263.9K | SEC ↗ |
| May 28, 2026 | Thomas Tray | Principal Accounting Officer | Sale | 2.1K | $97.35 | $199.7K | SEC ↗ |
| May 21, 2026 | Paul J Clancy | Director | Sale | 15.0K | $94.93 | $1.4M | SEC ↗ |
| Apr 21, 2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 18.7K | $96.50 | $1.8M | SEC ↗ |
| Mar 19, 2026 | Pablo J Cagnoni | President, R&D | Sale | 18.7K | $94.24 | $1.8M | SEC ↗ |
| Feb 23, 2026 | Pablo J Cagnoni | President, R&D | Sale | 18.7K | $100.91 | $1.9M | SEC ↗ |
| Jan 8, 2026 | Mohamed Khairie Issa | EVP, Head of US Oncology | Sale | 10.9K | $109.07 | $1.2M | SEC ↗ |
| Jan 7, 2026 | Steven H Stein | EVP & Chief Medical Officer | Sale | 15.6K | $101.70 | $1.6M | SEC ↗ |
| Dec 23, 2025 | Thomas Tray | Principal Accounting Officer | Sale | 3.4K | $99.69 | $336.4K | SEC ↗ |
| Dec 18, 2025 | Michael James Morrissey | EVP, Head of Tech. Operations | Sale | 58.3K | $97.29 | $5.7M | SEC ↗ |
| Dec 12, 2025 | Patrick A Mayes | EVP & Chief Scientific Officer | Sale | 5.8K | $95.55 | $555.0K | SEC ↗ |
| Dec 3, 2025 | Steven H Stein | EVP & Chief Medical Officer | Sale | 22.7K | $102.56 | $2.3M | SEC ↗ |
| Nov 25, 2025 | Thomas Tray | Principal Accounting Officer | Sale | 769 | $102.78 | $79.0K | SEC ↗ |
| Nov 19, 2025 | Sheila A. Denton | EVP & General Counsel | Sale | 278 | $104.36 | $29.0K | SEC ↗ |
| Nov 12, 2025 | Herve Hoppenot | Director | Sale | 187.5K | $105.46 | $19.8M | SEC ↗ |
Showing the 25 most recent of 189 Form 4 filings for INCYTE CORP.
Most active INCY insiders
- Barry P Flannelly22 filings
- Paula J Swain22 filings
- Dashyant Dhanak19 filings
- Steven H Stein17 filings
- Vijay K Iyengar17 filings
Ask anything about INCY insider activity
Use Trabud's AI agent to query INCYTE CORP's Form 4 history in plain English — "Show me INCY CEO purchases this year" or compare it against any other ticker.
Open the AI agentINCY insider trading FAQ
Are INCYTE CORP insiders buying or selling?
In the last 12 months, INCYTE CORP insiders reported 0 open-market purchases ($0) and 28 sales ($58.0M) — net selling of $58.0M. Since January 2018, Trabud has recorded 189 Form 4 filings for INCY: 8 buys ($288.3M) and 181 sells ($186.6M). Over the full record that is net buying of $101.7M.
How many insiders trade INCY stock?
24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for INCYTE CORP. The most recent filing was accepted on Sep 17, 2026.
Where does Trabud get INCY insider trading data?
All INCY insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.